A Rise in Neutrophil Cell Size Precedes Organ Dysfunction After Trauma.


Journal

Shock (Augusta, Ga.)
ISSN: 1540-0514
Titre abrégé: Shock
Pays: United States
ID NLM: 9421564

Informations de publication

Date de publication:
04 2019
Historique:
pubmed: 12 6 2018
medline: 6 5 2020
entrez: 12 6 2018
Statut: ppublish

Résumé

Organ dysfunction remains a major cause of morbidity after trauma. The development of organ dysfunction is determined by the inflammatory response, in which neutrophils are important effector cells. A femoral fracture particularly predisposes for the development of organ dysfunction. This study investigated the chronologic relation between neutrophil characteristics and organ dysfunction in trauma patients with a femoral fracture. Patients with a femoral fracture presenting at the University Medical Center Utrecht between 2007 and 2013 were included. Data of neutrophil characteristics from standard hematological analyzers were recorded on a daily basis until the 28th day of hospital stay or until discharge. Generalized Estimating Equations were used to compare outcome groups. In total 157 patients were analyzed, of whom 81 had polytrauma and 76 monotrauma. Overall mortality within 90 days was 6.4% (n = 10). Eleven patients (7.0%) developed organ dysfunction. In patients who developed organ dysfunction a significant increase in neutrophil count (P = 0.024), a significant increase in neutrophil cell size (P = 0.026), a significant increase in neutrophil complexity (P < 0.004), and a significant decrease in neutrophil lobularity (P < 0.001) were seen after trauma. The rise in neutrophil cell size preceded the clinical manifestation of organ dysfunction in every patient. Patients who develop organ dysfunction postinjury show changes in neutrophil characteristics before organ dysfunction becomes clinically evident. These findings regarding post-traumatic organ dysfunction may contribute to the development of new prognostic tools for immune-mediated complications in trauma patients. Level II, etiologic study.

Identifiants

pubmed: 29889813
doi: 10.1097/SHK.0000000000001200
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

439-446

Auteurs

Lillian Hesselink (L)

Department of Trauma Surgery, University Medical Center Utrecht, Utrecht, The Netherlands.

Marjolein Heeres (M)

Department of Trauma Surgery, University Medical Center Utrecht, Utrecht, The Netherlands.

Fotis Paraschiakos (F)

Department of Clinical Chemistry and Hematology, University Medical Center Utrecht, Utrecht, The Netherlands.

Maarten Ten Berg (M)

Department of Clinical Chemistry and Hematology, University Medical Center Utrecht, Utrecht, The Netherlands.

Albert Huisman (A)

Department of Clinical Chemistry and Hematology, University Medical Center Utrecht, Utrecht, The Netherlands.

Imo E Hoefer (IE)

Department of Clinical Chemistry and Hematology, University Medical Center Utrecht, Utrecht, The Netherlands.

Mark C H de Groot (MCH)

Department of Clinical Chemistry and Hematology, University Medical Center Utrecht, Utrecht, The Netherlands.

Wouter W van Solinge (WW)

Department of Clinical Chemistry and Hematology, University Medical Center Utrecht, Utrecht, The Netherlands.

Marcel Dijkgraaf (M)

Clinical Research Unit, Academic Medical Center, Amsterdam, The Netherlands.

Pien Hellebrekers (P)

Department of Trauma Surgery, University Medical Center Utrecht, Utrecht, The Netherlands.

Karlijn J P Van Wessem (KJP)

Department of Trauma Surgery, University Medical Center Utrecht, Utrecht, The Netherlands.

Leo Koenderman (L)

Laboratory for Translational Immunology and Department of Respiratory Medicine, Wilhelmina Children's Hospital, Utrecht, The Netherlands.

Luke P H Leenen (LPH)

Department of Trauma Surgery, University Medical Center Utrecht, Utrecht, The Netherlands.

Falco Hietbrink (F)

Department of Trauma Surgery, University Medical Center Utrecht, Utrecht, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH